Antivirals and Therapeutics for Flu disease

Antiviral drugs are prescription medicines that fight agaist the flu in your body. The two classes of antiviral drugs used against influenza are neuraminidase inhibitors (oseltamivir and zanamivir) and M2 protein inhibitors (adamantane derivatives). Food and Drug Administration (FDA) and European Agency for the Evaluation of Medicinal Products(EMEA), now a days force developers as well as manufacturers to improve their production and purification processes for viral vectors and vaccines.

  • Antiviral drugs for influenza
  • Antiviral drug development and treatment strategies, including vaccination
  • Advances in viral detection and identification technologies
  • Antibiotic and antimicrobial resistance during flu infection
  • National and international surveillance and contingency strategies
  • Antibiotic and antimicrobial resistance during flu infection

Related Conference of Antivirals and Therapeutics for Flu disease

October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
July 23-25, 2018

11th World Congress on Infectious Diseases and Therapy

Melbourne, Australia
August 27-28, 2018

9th International Conference on Emerging Infectious Diseases

Zurich, Switzerland
September 17-18, 2018

4th Annual Congress on Infectious Diseases

San Diego, USA
September 27-29, 2018

10thEuro-Global Conference on Infectious Diseases

Rome, Italy
Sep 17-18, 2018

3rd International Conference on Infection Control

San Diego, California, USA

Antivirals and Therapeutics for Flu disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in